{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:06:44Z","timestamp":1779307604075,"version":"3.51.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2003,7,15]],"date-time":"2003-07-15T00:00:00Z","timestamp":1058227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,7,15]],"date-time":"2003-07-15T00:00:00Z","timestamp":1058227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO J"],"published-print":{"date-parts":[[2003,7,15]]},"DOI":"10.1093\/emboj\/cdg338","type":"journal-article","created":{"date-parts":[[2003,7,9]],"date-time":"2003-07-09T17:41:27Z","timestamp":1057772487000},"page":"3473-3478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Molecular background of progressive myoclonus epilepsy"],"prefix":"10.1038","volume":"22","author":[{"given":"Anna\u2010Elina","family":"Lehesjoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,7,15]]},"reference":[{"key":"BFEMBJ7595248_CR1","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1016\/S0021-9258(18)67380-6","volume":"261","author":"M Abrahamson","year":"1986","unstructured":"Abrahamson M, Barrett AJ, Salvesen G and Grubb A (1986) Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem, 261, 11282\u201311289.","journal-title":"J Biol Chem"},{"key":"BFEMBJ7595248_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0378-1119(99)00550-8","volume":"242","author":"K Alakurtti","year":"2000","unstructured":"Alakurtti K, Virtaneva K, Joensuu T, Palvimo JJ and Lehesjoki A\u2010E (2000) Characterization of the cystatin B gene promoter harboring the dodecamer repeat expanded in progressive myoclonus epilepsy, EPM1. Gene, 242, 65\u201373.","journal-title":"Gene"},{"key":"BFEMBJ7595248_CR3","first-page":"1363","volume":"45","author":"AJ Barrett","year":"1986","unstructured":"Barrett AJ (1986) The cystatins, a diverse superfamily of cysteine peptidase inhibitors. Biomed Biochim Acta, 45, 1363\u20131373.","journal-title":"Biomed Biochim Acta"},{"key":"BFEMBJ7595248_CR4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1042\/bj2360312","volume":"236","author":"AJ Barrett","year":"1986","unstructured":"Barrett AJ et al. (1986) Nomenclature and classification of the proteins homologous with the cysteine\u2010proteinase inhibitor chicken cystatin. Biochem J, 236, 312.","journal-title":"Biochem J"},{"key":"BFEMBJ7595248_CR5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM198607313150506","volume":"315","author":"SF Berkovic","year":"1986","unstructured":"Berkovic SF, Andermann F, Carpenter S and Wolfe L (1986) Progressive myoclonus epilepsies: specific causes and diagnosis. N Engl J Med, 315, 296\u2013304.","journal-title":"N Engl J Med"},{"key":"BFEMBJ7595248_CR6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/(SICI)1096-8628(19970919)74:5<467::AID-AJMG1>3.0.CO;2-L","volume":"74","author":"IN Bespalova","year":"1997","unstructured":"Bespalova IN, Adkins S, Pranzatelli M and Burmeister M (1997a) Novel cystatin B mutation and diagnostic PCR assay in an Unverricht\u2013Lundborg progressive myoclonus epilepsy patient. Am J Med Genet, 74, 467\u2013471.","journal-title":"Am J Med Genet"},{"key":"BFEMBJ7595248_CR7","first-page":"67","volume":"382","author":"IN Bespalova","year":"1997","unstructured":"Bespalova IN, Pranzatelli M and Burmeister M (1997b) G to C transversion at a splice acceptor site causes exon skipping in the cystatin B gene. Mutat Res Gen, 382, 67\u201374.","journal-title":"Mutat Res Gen"},{"key":"BFEMBJ7595248_CR8","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/j.1460-2075.1988.tb03109.x","volume":"7","author":"W Bode","year":"1988","unstructured":"Bode W, Engh R, Musil D, Thiele U, Huber R, Karshikov A, Brzin J, Kos J and Turk V (1988) The 2.0 \u00c5 X\u2010ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J, 7, 2593\u20132599.","journal-title":"EMBO J"},{"key":"BFEMBJ7595248_CR9","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1101\/gad.10.24.3156","volume":"10","author":"E Bonten","year":"1996","unstructured":"Bonten E, van der Spoel A, Fornerod M, Grosveld G and d'Azzo A (1996) Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev, 10, 3156\u20133169.","journal-title":"Genes Dev"},{"key":"BFEMBJ7595248_CR10","first-page":"631","volume":"50","author":"D Br\u00f6mme","year":"1991","unstructured":"Br\u00f6mme D, Rinne R and Kirschke H (1991) Tight\u2010binding inhibition of cathepsin S by cystatins. Biomed Biochim Acta, 50, 631\u2013635.","journal-title":"Biomed Biochim Acta"},{"key":"BFEMBJ7595248_CR11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/002215549804600607","volume":"46","author":"CC Calkins","year":"1998","unstructured":"Calkins CC, Sameni M, Koblinski J, Sloane BF and Moin K (1998) Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno\u2010confocal microscopy. J Histochem Cytochem, 46, 745\u2013751.","journal-title":"J Histochem Cytochem"},{"key":"BFEMBJ7595248_CR12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1046\/j.1460-9568.2000.00058.x","volume":"12","author":"E D'Amato","year":"2000","unstructured":"D'Amato E, Kokaia Z, Nanobashvili A, Reeben M, Lehesjoki A\u2010E, Saarma M and Linvall O (2000) Seizures induce widespread upregulation of cystatin B, the gene mutated in progressive myoclonus epilepsy, in rat forebrain neurons. Eur J Neurosci, 12, 1687\u20131695.","journal-title":"Eur J Neurosci"},{"key":"BFEMBJ7595248_CR13","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1093\/hmg\/11.23.2941","volume":"11","author":"R DiGiaimo","year":"2002","unstructured":"DiGiaimo R, Riccio M, Santi S, Galeotti C, Ambrosetti DC and Melli M (2002) New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B. Hum Mol Genet, 11, 2941\u20132950.","journal-title":"Hum Mol Genet"},{"key":"BFEMBJ7595248_CR14","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(83)90749-3","volume":"2","author":"R Eldridge","year":"1983","unstructured":"Eldridge R, Iivanainen M, Stern R, Koerber T and Wilder BJ (1983) \u2018Baltic\u2019 myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet, 2, 838\u2013842.","journal-title":"Lancet"},{"key":"BFEMBJ7595248_CR15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.7732383","volume":"268","author":"Y Feng","year":"1995","unstructured":"Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D and Warren ST (1995) Translational suppression by trinucleotide repeat expansion at FMR1. Science, 268, 731\u2013734.","journal-title":"Science"},{"key":"BFEMBJ7595248_CR16","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/oxfordjournals.hmg.a018916","volume":"9","author":"S Ganesh","year":"2000","unstructured":"Ganesh S et al. (2000) Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual\u2010specificity phosphatase associated with polyribosomes. Hum Mol Genet, 9, 2251\u20132261.","journal-title":"Hum Mol Genet"},{"key":"BFEMBJ7595248_CR17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1086\/338190","volume":"70","author":"H Gao","year":"2002","unstructured":"Gao H et al. (2002) Mutations in a novel CLN6\u2010encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am J Hum Genet, 70, 324\u2013335.","journal-title":"Am J Hum Genet"},{"key":"BFEMBJ7595248_CR18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1042\/bj2180939","volume":"218","author":"GD Green","year":"1984","unstructured":"Green GD, Kembhavi AA, Davies ME and Barret AJ (1984) Cystatin\u2010like cysteine proteinase inhibitors from human liver. Biochem J, 218, 939\u2013946.","journal-title":"Biochem J"},{"key":"BFEMBJ7595248_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0404.1969.tb01220.x","volume":"45","author":"M Haltia","year":"1969","unstructured":"Haltia M, Kristensson K and Sourander P (1969) Neuropathological studies in three Scandinavian cases of progressive myoclonus epilepsy. Acta Neurol Scand, 45, 63\u201377.","journal-title":"Acta Neurol Scand"},{"key":"BFEMBJ7595248_CR20","doi-asserted-by":"crossref","unstructured":"International Batten Disease Consortium (1995) Isolation of a novel gene underlying Batten Disease, CLN3. Cell, 82, 949\u2013957.","DOI":"10.1016\/0092-8674(95)90274-0"},{"key":"BFEMBJ7595248_CR21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0167-4838(82)90222-9","volume":"708","author":"M J\u00e4rvinen","year":"1982","unstructured":"J\u00e4rvinen M and Rinne A (1982) Human spleen cysteine protease inhibitor. Purification, fractionation into isoelectric variants and some properties of the variants. Biochim Biophys Acta, 708, 210\u2013217.","journal-title":"Biochim Biophys Acta"},{"key":"BFEMBJ7595248_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-5793(88)80541-6","volume":"239","author":"R Jerala","year":"1988","unstructured":"Jerala R, Trstenjak M, Lenarcic B and Turk V (1988) Cloning a synthetic gene for human stefin B and its expression in E.coli. FEBS Lett, 239, 41\u201344.","journal-title":"FEBS Lett"},{"key":"BFEMBJ7595248_CR23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0887-8994(01)00336-8","volume":"26","author":"K Kagitani\u2010Shimono","year":"2002","unstructured":"Kagitani\u2010Shimono K, Imai K, Okamoto N, Ono J and Okada S (2002) Unverricht\u2013Lundborg disease with cystatin B gene abnormalities. Pediatr Neurol, 26, 55\u201360.","journal-title":"Pediatr Neurol"},{"key":"BFEMBJ7595248_CR24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ng0194-9","volume":"6","author":"R Koide","year":"1994","unstructured":"Koide R et al. (1994) Unstable expansion of CAG repeat in hereditary dentatorubral\u2013pallidoluysian atrophy (DRPLA). Nat Genet, 6, 9\u201313.","journal-title":"Nat Genet"},{"key":"BFEMBJ7595248_CR25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0404.1974.tb02782.x","volume":"50","author":"M Koskiniemi","year":"1974","unstructured":"Koskiniemi M, Donner M, Majuri H, Haltia M and Norio R (1974a) Progressive myoclonus epilepsy: a clinical and histopathologic study. Acta Neurol Scand, 50, 307\u2013332.","journal-title":"Acta Neurol Scand"},{"key":"BFEMBJ7595248_CR26","first-page":"333","volume":"30","author":"M Koskiniemi","year":"1974","unstructured":"Koskiniemi M, Toivakka E and Donner M (1974b) Progressive myoclonus epilepsy: electroencephalographical findings. Acta Neurol Scand, 30, 333\u2013359.","journal-title":"Acta Neurol Scand"},{"key":"BFEMBJ7595248_CR27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ng0397-298","volume":"15","author":"RG Lafreniere","year":"1997","unstructured":"Lafreniere RG et al. (1997) Unstable insertion in the 5\u2032\u2010flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet, 15, 298\u2013302.","journal-title":"Nat Genet"},{"key":"BFEMBJ7595248_CR28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/386847a0","volume":"386","author":"MD Lalioti","year":"1997","unstructured":"Lalioti MD, Scott HS, Buresi C, Rossier C, Bottani A, Morris MA, Malafosse A and Antonarakis SE (1997a) Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature, 386, 847\u2013851.","journal-title":"Nature"},{"key":"BFEMBJ7595248_CR29","first-page":"342","volume":"60","author":"MD Lalioti","year":"1997","unstructured":"Lalioti MD et al. (1997b) Identification of mutations in cystatin B, the gene responsible for the Unverricht\u2013Lundborg type of progressive myoclonus epilepsy (EPM1). Am J Hum Genet, 60, 342\u2013351.","journal-title":"Am J Hum Genet"},{"key":"BFEMBJ7595248_CR30","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/301798","volume":"62","author":"MD Lalioti","year":"1998","unstructured":"Lalioti MD et al. (1998) A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset. Am J Hum Genet, 62, 842\u2013847.","journal-title":"Am J Hum Genet"},{"key":"BFEMBJ7595248_CR31","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/hmg\/8.9.1791","volume":"8","author":"MD Lalioti","year":"1999","unstructured":"Lalioti MD, Scott HS and Antonarakis SE (1999) Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1. Hum Mol Genet, 8, 1791\u20131798.","journal-title":"Hum Mol Genet"},{"key":"BFEMBJ7595248_CR32","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/hmg\/8.11.1985","volume":"8","author":"GP Larson","year":"1999","unstructured":"Larson GP, Ding S, Lafreni\u00e8re RG, Rouleau GA and Krontiris TG (1999) Instability of the EPM1 minisatellite. Hum Mol Genet, 8, 1985\u20131988.","journal-title":"Hum Mol Genet"},{"key":"BFEMBJ7595248_CR33","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1073\/pnas.88.9.3696","volume":"883","author":"A\u2010E Lehesjoki","year":"1991","unstructured":"Lehesjoki A\u2010E, Koskiniemi M, Sistonen P, Miao J, H\u00e4stbacka J, Norio R and de la Chapelle A (1991) Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proc Natl Acad Sci USA, 883, 3696\u20133699.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ7595248_CR34","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/hmg\/2.8.1229","volume":"2","author":"A\u2010E Lehesjoki","year":"1993","unstructured":"Lehesjoki A\u2010E, Koskiniemi M, Norio R, Tirrito S, Sistonen P, Lander E and de la Chapelle A (1993) Localization of the EPM1 gene for progressive myoclonus epilepsy on chromosome 21: linkage disequilibrium allows high resolution mapping. Hum Mol Genet, 2, 1229\u20131234.","journal-title":"Hum Mol Genet"},{"key":"BFEMBJ7595248_CR35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-5793(96)00984-2","volume":"395","author":"B Lenarcic","year":"1996","unstructured":"Lenarcic B, Krizaj I, Zunec P and Turk V (1996) Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases. FEBS Lett, 395, 113\u2013118.","journal-title":"FEBS Lett"},{"key":"BFEMBJ7595248_CR36","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/hmg\/10.18.1867","volume":"10","author":"K Lieuallen","year":"2001","unstructured":"Lieuallen K, Pennacchio LA, Park M, Myers RM and Lennon GG (2001) Cystatin B\u2010deficient mice have increased expression of apoptosis and glial activation genes. Hum Mol Genet, 10, 1867\u20131871.","journal-title":"Hum Mol Genet"},{"key":"BFEMBJ7595248_CR37","first-page":"613","volume":"50","author":"W Machleidt","year":"1991","unstructured":"Machleidt W, Thiele U, Assfalg\u2010Machleidt I, Forger D and Auerswald EA (1991) Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins. Biomed Biochim Acta, 50, 613\u2013620.","journal-title":"Biomed Biochim Acta"},{"key":"BFEMBJ7595248_CR38","doi-asserted-by":"crossref","unstructured":"Marseille Consensus Group (1990) Classification of progressive myoclonus epilepsies and related disorders. Ann Neurol, 28, 113\u2013116.","DOI":"10.1002\/ana.410280129"},{"key":"BFEMBJ7595248_CR39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/2470","volume":"20","author":"BA Minassian","year":"1998","unstructured":"Minassian BA et al. (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet, 20, 171\u2013174.","journal-title":"Nat Genet"},{"key":"BFEMBJ7595248_CR40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ng0194-14","volume":"6","author":"S Nagafuchi","year":"1994","unstructured":"Nagafuchi S et al. (1994) Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet, 6, 14\u201318.","journal-title":"Nat Genet"},{"key":"BFEMBJ7595248_CR41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1399-0004.1979.tb01770.x","volume":"15","author":"R Norio","year":"1979","unstructured":"Norio R and Koskiniemi M (1979) Progressive myoclonus epilepsy; genetic and nosological aspects with special reference to 107 Finnish patients. Clin Genet, 15, 382\u2013398.","journal-title":"Clin Genet"},{"key":"BFEMBJ7595248_CR42","doi-asserted-by":"crossref","first-page":"26998","DOI":"10.1074\/jbc.273.41.26998","volume":"273","author":"MA Parsons","year":"1998","unstructured":"Parsons MA, Sinden RR and Izban MG (1998) Transcriptional properties of RNA polymerase II within triplet repeat\u2010containing DNA from the human myotonic dystrophy and fragile X loci. J Biol Chem, 273, 26998\u201327008.","journal-title":"J Biol Chem"},{"key":"BFEMBJ7595248_CR43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/07391102.2001.10506740","volume":"19","author":"SS Pataskar","year":"2001","unstructured":"Pataskar SS, Dash D and Brahmachari SK (2001) Progressive myoclonus epilepsy [EPM1] repeat d(CCCCGCCCCGCG)n forms folded hairpin structures at physiological pH. J Biomol Struct Dyn, 19, 293\u2013305.","journal-title":"J Biomol Struct Dyn"},{"key":"BFEMBJ7595248_CR44","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.271.5256.1731","volume":"271","author":"LA Pennacchio","year":"1996","unstructured":"Pennacchio LA et al. (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science, 271, 1731\u20131734.","journal-title":"Science"},{"key":"BFEMBJ7595248_CR45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/3059","volume":"20","author":"LA Pennacchio","year":"1998","unstructured":"Pennacchio LA, Bouley DM, Higgins KM, Scott MP, Noebels JL and Myers RM (1998) Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B\u2010deficient mice. Nat Genet, 20, 251\u2013258.","journal-title":"Nat Genet"},{"key":"BFEMBJ7595248_CR46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng0397-316","volume":"15","author":"AV Pshezhetsky","year":"1997","unstructured":"Pshezhetsky AV et al. (1997) Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat Genet, 15, 316\u2013320.","journal-title":"Nat Genet"},{"key":"BFEMBJ7595248_CR47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/13868","volume":"23","author":"S Ranta","year":"1999","unstructured":"Ranta S et al. (1999) The neuronal ceroid lipofuscinosis in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet, 23, 233\u2013236.","journal-title":"Nat Genet"},{"key":"BFEMBJ7595248_CR48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF02102453","volume":"30","author":"ND Rawlings","year":"1990","unstructured":"Rawlings ND and Barret AJ (1990) Evolution of proteins of the cystatin superfamily. J Mol Evol, 30, 60\u201371.","journal-title":"J Mol Evol"},{"key":"BFEMBJ7595248_CR49","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0167-4838(98)00238-6","volume":"1429","author":"ND Rawlings","year":"1999","unstructured":"Rawlings ND and Barrett AJ (1999) Tripeptidyl\u2010peptidase I is apparently the CLN2 protein absent in classical late\u2010infantile neuronal ceroid lipofuscinosis. Biochim Biophys Acta, 1429, 496\u2013500.","journal-title":"Biochim Biophys Acta"},{"key":"BFEMBJ7595248_CR50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/excr.2000.5085","volume":"262","author":"M Riccio","year":"2001","unstructured":"Riccio M, Di Giaimo R, Pianetti S, Palmieri PP, Melli M and Santi S (2001) Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Exp Cell Res, 262, 84\u201394.","journal-title":"Exp Cell Res"},{"key":"BFEMBJ7595248_CR51","first-page":"573","volume":"75","author":"A Rinne","year":"1981","unstructured":"Rinne A, J\u00e4rvinen M, Martikainen J, Alavaikko M and R\u00e4s\u00e4nen O (1981) \u00dcber das Vorkommen des epidermalen SH\u2010Protease\u2010Inhibitors im lymphatischen Gewebe. Verb Anat Ges, 75, 573\u2013574.","journal-title":"Verb Anat Ges"},{"key":"BFEMBJ7595248_CR52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/078538902320772124","volume":"34","author":"R Rinne","year":"2002","unstructured":"Rinne R, Saukko P, J\u00e4rvinen M and Lehesjoki A\u2010E (2002) Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy. Ann Med, 34, 380\u2013385.","journal-title":"Ann Med"},{"key":"BFEMBJ7595248_CR53","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0006-291X(85)90216-5","volume":"131","author":"A Ritonja","year":"1985","unstructured":"Ritonja A, Machleidt W and Barrett AJ (1985) Amino acid sequence of the intracellular cysteine proteinase inhibitor cystatin B from human liver. Biochem Biophys Res Commun, 131, 1187\u20131192.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFEMBJ7595248_CR54","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0014-5793(01)02190-1","volume":"491","author":"T Saha","year":"2001","unstructured":"Saha T and Ushdin K (2001) Tetraplex formation by the progressive myoclonus epilepsy type\u20101 repeat: implications for instability in the repeat expansion diseases. FEBS Lett 491, 184\u2013187.","journal-title":"FEBS Lett"},{"key":"BFEMBJ7595248_CR55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/975","volume":"19","author":"M Savukoski","year":"1998","unstructured":"Savukoski M, Klockars T, Holmberg V, Santavuori P, Lander ES and Peltonen L (1998) CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet, 19, 286\u2013288.","journal-title":"Nat Genet"},{"key":"BFEMBJ7595248_CR56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/8.2.345","volume":"8","author":"JM Serratosa","year":"1999","unstructured":"Serratosa JM et al. (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet, 8, 345\u2013352.","journal-title":"Hum Mol Genet"},{"key":"BFEMBJ7595248_CR57","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/jnen\/61.12.1085","volume":"61","author":"P Shannon","year":"2002","unstructured":"Shannon P, Pennacchio LA, Houseweart MK, Minassian BA and Myers RM (2002) Neuropathological changes in a mouse model of progressive myoclonus epilepsy: cystatin B deficiency and Unverricht\u2013Lundborg disease. J Neuropathol Exp Neurol, 61, 1085\u20131091.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFEMBJ7595248_CR58","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0092-8674(90)90059-N","volume":"61","author":"JM Shoffner","year":"1990","unstructured":"Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW and Wallace DC (1990) Myoclonic epilepsy and ragged\u2010red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell, 61, 931\u2013937.","journal-title":"Cell"},{"key":"BFEMBJ7595248_CR59","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","volume":"277","author":"DE Sleat","year":"1997","unstructured":"Sleat DE, Donnelly RJ, Lackland H, Liu CG, Sohar I, Pullarkat RK and Lobel P (1997) Association of mutations in a lysosomal protein with classical late\u2010infantile neuronal ceroid lipofuscinosis. Science, 277, 1802\u20131805.","journal-title":"Science"},{"key":"BFEMBJ7595248_CR60","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1101\/gr.6.3.218","volume":"6","author":"NE Stone","year":"1996","unstructured":"Stone NE et al. (1996) Construction of a 750 kb bacterial clone contig and restriction map in the region of human chromosome 21 containing the progressive myoclonus epilepsy (EPM1) gene. Genome Res, 6, 218\u2013225.","journal-title":"Genome Res"},{"key":"BFEMBJ7595248_CR61","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/j.1460-2075.1990.tb08321.x","volume":"9","author":"MT Stubbs","year":"1990","unstructured":"Stubbs MT, Laber B, Bode W, Huber R, Jerala R, Lenarcic B and Turk V (1990) The refined 2.4 \u00c5 X\u2010ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J, 9, 1939\u20131947.","journal-title":"EMBO J"},{"key":"BFEMBJ7595248_CR62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-5793(91)80804-C","volume":"285","author":"V Turk","year":"1991","unstructured":"Turk V and Bode W (1991) The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett, 285, 213\u2013219.","journal-title":"FEBS Lett"},{"key":"BFEMBJ7595248_CR63","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/376584a0","volume":"376","author":"J Vesa","year":"1995","unstructured":"Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hoffmann SL and Peltonen L (1995) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature, 376, 584\u2013587.","journal-title":"Nature"},{"key":"BFEMBJ7595248_CR64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-5793(98)01683-4","volume":"443","author":"DJ Vines","year":"1999","unstructured":"Vines DJ and Warburton MJ (1999) Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I. FEBS Lett, 443, 131\u2013135.","journal-title":"FEBS Lett"},{"key":"BFEMBJ7595248_CR65","first-page":"1247","volume":"58","author":"K Virtaneva","year":"1996","unstructured":"Virtaneva K et al. (1996) Progressive myoclonus epilepsy EPM1 locus maps to a 175 kb interval in distal 21q. Am J Hum Genet, 58, 1247\u20131253.","journal-title":"Am J Hum Genet"},{"key":"BFEMBJ7595248_CR66","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng0497-393","volume":"15","author":"K Virtaneva","year":"1997","unstructured":"Virtaneva K et al. (1997) Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet, 15, 393\u2013396.","journal-title":"Nat Genet"},{"key":"BFEMBJ7595248_CR67","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1086\/338708","volume":"70","author":"RB Wheeler","year":"2002","unstructured":"Wheeler RB, Sharp JD, Schultz RA, Joslin JM, Williams RE and Mole SE (2002) The gene mutated in variant late\u2010infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein Am J Hum Genet, 70, 537\u2013542.","journal-title":"Am J Hum Genet"},{"key":"BFEMBJ7595248_CR68","first-page":"789","volume":"21","author":"M Yoneda","year":"1990","unstructured":"Yoneda M, Tanno Y, Horai S, Ozawa T, Miyatake T and Tsuji S (1990) A common mitochondrial DNA mutation in the tRNA\u2010lys of patients with myoclonus epilepsy associated with ragged\u2010red fibers. Biochem Int, 21, 789\u2013796.","journal-title":"Biochem Int"}],"container-title":["The EMBO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Femboj%2Fcdg338","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1093\/emboj\/cdg338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1093\/emboj\/cdg338\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1093\/emboj\/cdg338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1093\/emboj\/cdg338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:18:28Z","timestamp":1779304708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1093\/emboj\/cdg338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,15]]},"references-count":68,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2003,7,15]]}},"alternative-id":["BFEMBJ7595248"],"URL":"https:\/\/doi.org\/10.1093\/emboj\/cdg338","relation":{},"ISSN":["0261-4189","1460-2075"],"issn-type":[{"value":"0261-4189","type":"print"},{"value":"1460-2075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,15]]},"assertion":[{"value":"10 January 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2003","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2003","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2003","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}